1. Home
  2. LGVN vs IVDA Comparison

LGVN vs IVDA Comparison

Compare LGVN & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • IVDA
  • Stock Information
  • Founded
  • LGVN 2014
  • IVDA 2003
  • Country
  • LGVN United States
  • IVDA United States
  • Employees
  • LGVN N/A
  • IVDA N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • IVDA Computer Software: Prepackaged Software
  • Sector
  • LGVN Health Care
  • IVDA Technology
  • Exchange
  • LGVN Nasdaq
  • IVDA Nasdaq
  • Market Cap
  • LGVN 23.4M
  • IVDA 6.7M
  • IPO Year
  • LGVN 2021
  • IVDA N/A
  • Fundamental
  • Price
  • LGVN $1.43
  • IVDA $2.19
  • Analyst Decision
  • LGVN Strong Buy
  • IVDA
  • Analyst Count
  • LGVN 3
  • IVDA 0
  • Target Price
  • LGVN $8.67
  • IVDA N/A
  • AVG Volume (30 Days)
  • LGVN 711.7K
  • IVDA 78.9K
  • Earning Date
  • LGVN 08-13-2025
  • IVDA 08-13-2025
  • Dividend Yield
  • LGVN N/A
  • IVDA N/A
  • EPS Growth
  • LGVN N/A
  • IVDA N/A
  • EPS
  • LGVN N/A
  • IVDA N/A
  • Revenue
  • LGVN $2,225,000.00
  • IVDA $7,148,449.00
  • Revenue This Year
  • LGVN N/A
  • IVDA $340.48
  • Revenue Next Year
  • LGVN $51.48
  • IVDA N/A
  • P/E Ratio
  • LGVN N/A
  • IVDA N/A
  • Revenue Growth
  • LGVN 127.50
  • IVDA 54.15
  • 52 Week Low
  • LGVN $1.14
  • IVDA $1.27
  • 52 Week High
  • LGVN $4.94
  • IVDA $8.05
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 59.84
  • IVDA 51.25
  • Support Level
  • LGVN $1.27
  • IVDA $1.76
  • Resistance Level
  • LGVN $1.40
  • IVDA $2.44
  • Average True Range (ATR)
  • LGVN 0.11
  • IVDA 0.18
  • MACD
  • LGVN 0.04
  • IVDA 0.04
  • Stochastic Oscillator
  • LGVN 61.40
  • IVDA 57.53

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).

Share on Social Networks: